"I’m running for her and so many people like her. To show them that there is always a finish line." The post ‘She is truly a ...

Imagine a tiny superhero inside every cell of your body whose job is to stop damaged cells before they turn dangerous. That superhero is a gene called TP53, and for decades scientists have known it as ...

Jake Fraley and his family had been waiting years for Thursday. It was a day of celebration. A day of gratitude. A day to ...

Fifth-grader Levi Buxman of Wooster has amassed more than 4,000 beads signifying various aspects of treatment for B-cell ...

Each year around St. Patrick’s Day, a group of supporters known as “shave-ees” ditches their locks to raise awareness and funds for kids’ cancer research. It is all for an event known as ...

Gilead plans a $7.8B Arcellx acquisition as cell therapy sales decline, seeking full control of anito-cel to strengthen its oncology pipeline.

DelveInsight's CD-19 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, addressable ...

Ten-year-old Emma didn’t ask for toys. She didn’t ask for a trip. She asked for... a wedding. Emma Brooks Edwards was 10 ...

Chief Executive Officer Christian Itin told conference attendees the company is entering its second year as a commercial-stage business following the launch of its first product, obe-cel, a CD19 CAR-T ...

Children with cancer received aid and gifts from the GMA Kapuso Foundation under its Kapuso Cancer Champions project.

Blackstone Life Sciences announced a research and development funding agreement to advance the clinical development of bleximenib, an investigational oral menin inhibitor, for acute myeloid leukemia ...